Literature DB >> 18664598

Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.

Byoung Geun Han1, Chuan-Ming Hao, Elena E Tchekneva, Ying-Ying Wang, Chieh Allen Lee, Benyamin Ebrahim, Raymond C Harris, Timothy S Kern, David H Wasserman, Matthew D Breyer, Zhonghua Qi.   

Abstract

The present studies examined the relationship between fasting blood glucose and Hb A(1c) in C57BL/6J, DBA/2J, and KK/HlJ mice with and without diabetes mellitus. Daily averaged blood glucose levels based on continuous glucose monitoring and effects of 6-h vs. overnight fasting on blood glucose were determined. Daily averaged blood glucose levels were highly correlated with Hb A(1c), as determined with a hand-held automated device using an immunodetection method. R(2) values were 0.90, 0.95, and 0.99 in KK/HIJ, C57BL/6J, and DBA/2J, respectively. Six-hour fasting blood glucose correlated more closely with the level of daily averaged blood glucose and with Hb A(1c) than did blood glucose following an overnight fast. To validate the immunoassay-determined Hb A(1c), we also measured total glycosylated hemoglobin using boronate HPLC. Hb A(1c) values correlated well with total glycosylated hemoglobin in all three strains but were relatively lower than total glycosylated hemoglobin in diabetic DBA/2J mice. These results show that 6-h fasting glucose provides a superior index of glycemic control and correlates more closely with Hb A(1c) than overnight-fasted blood glucose in these strains of mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664598      PMCID: PMC2575908          DOI: 10.1152/ajpendo.90283.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  35 in total

1.  Inherited electrophoretic hemoglobin patterns among 20 inbred strains of mice.

Authors:  E S RUSSELL; P S GERALD
Journal:  Science       Date:  1958-12-19       Impact factor: 47.728

2.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

3.  Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group.

Authors:  B Guerci; D Durain; H Leblanc; J C Rouland; P Passa; T Godeau; B Charbonnel; J C Mathieu Daude; H Boniface; L Monnier; F Dauchy; G Slama; P Drouin
Journal:  Diabetes Metab       Date:  1997-06       Impact factor: 6.041

4.  What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry.

Authors:  K P Peterson; J G Pavlovich; D Goldstein; R Little; J England; C M Peterson
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

Review 5.  Mouse models of diabetic nephropathy.

Authors:  Matthew D Breyer; Erwin Böttinger; Frank C Brosius; Thomas M Coffman; Raymond C Harris; Charles W Heilig; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

6.  How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

Authors:  M Bouma; J H Dekker; J J de Sonnaville; F E van der Does; H de Vries; D M Kriegsman; P J Kostense; R J Heine; J T van Eijk
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

7.  Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.

Authors:  K Rebrin; G M Steil; W P van Antwerp; J J Mastrototaro
Journal:  Am J Physiol       Date:  1999-09

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice.

Authors:  J Suto; S Matsuura; K Imamura; H Yamanaka; K Sekikawa
Journal:  Eur J Endocrinol       Date:  1998-12       Impact factor: 6.664

View more
  27 in total

1.  Characterization of a mouse model of hyperglycemia and retinal neovascularization.

Authors:  Elizabeth P Rakoczy; Ireni S Ali Rahman; Nicolette Binz; Cai-Rui Li; Nermina N Vagaja; Marisa de Pinho; Chooi-May Lai
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

2.  Barriers in translating preclinical rodent exercise metabolism findings to human health.

Authors:  Kelly N Z Fuller; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2020-11-12

3.  Phenotypic characterization of the KK/HlJ inbred mouse strain.

Authors:  A Berndt; B A Sundberg; K A Silva; V E Kennedy; M A Richardson; Q Li; R T Bronson; J Uitto; J P Sundberg
Journal:  Vet Pathol       Date:  2013-09-05       Impact factor: 2.221

4.  Streptococcus pneumoniae Senses a Human-like Sialic Acid Profile via the Response Regulator CiaR.

Authors:  Karina Hentrich; Jonas Löfling; Anuj Pathak; Victor Nizet; Ajit Varki; Birgitta Henriques-Normark
Journal:  Cell Host Microbe       Date:  2016-09-01       Impact factor: 21.023

5.  Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse.

Authors:  LaTayia M Aaron-Brooks; Takeshi Sasaki; Renee E Vickman; Lin Wei; Omar E Franco; Yuan Ji; Susan E Crawford; Simon W Hayward
Journal:  Prostate       Date:  2019-04-18       Impact factor: 4.104

Review 6.  NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse.

Authors:  Owen P McGuinness; Julio E Ayala; Maren R Laughlin; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-28       Impact factor: 4.310

7.  Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.

Authors:  Kathryn M Thrailkill; R Clay Bunn; Sasidhar Uppuganti; Philip Ray; Iuliana Popescu; Evangelia Kalaitzoglou; John L Fowlkes; Jeffry S Nyman
Journal:  Bone       Date:  2020-09-02       Impact factor: 4.398

8.  LKB1-AMPK modulates nutrient-induced changes in the mode of division of intestinal epithelial crypt cells in mice.

Authors:  Katherine Blackmore; Weinan Zhou; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-02

9.  The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.

Authors:  Guillaume Arguin; Jean-François Bourzac; Morgane Placet; Caroline M Molle; Michel Paquette; Jean-François Beaudoin; Jacques A Rousseau; Roger Lecomte; Mélanie Plourde; Fernand-Pierre Gendron
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

Review 10.  Approach to assessing determinants of glucose homeostasis in the conscious mouse.

Authors:  Curtis C Hughey; David H Wasserman; Robert S Lee-Young; Louise Lantier
Journal:  Mamm Genome       Date:  2014-07-30       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.